203 related articles for article (PubMed ID: 28654780)
1. Development and validation of an ICP-MS method for the determination of elemental impurities in TP-6076 active pharmaceutical ingredient (API) according to USP 〈232〉/〈233〉.
Chahrour O; Malone J; Collins M; Salmon V; Greenan C; Bombardier A; Ma Z; Dunwoody N
J Pharm Biomed Anal; 2017 Oct; 145():84-90. PubMed ID: 28654780
[TBL] [Abstract][Full Text] [Related]
2. Flow injection combined with ICP-MS for accurate high throughput analysis of elemental impurities in pharmaceutical products according to USP <232>/<233>.
Fischer L; Zipfel B; Koellensperger G; Kovac J; Bilz S; Kunkel A; Venzago C; Hann S
J Pharm Biomed Anal; 2014 Jul; 95():121-9. PubMed ID: 24667566
[TBL] [Abstract][Full Text] [Related]
3. Study and determination of elemental impurities by ICP-MS in active pharmaceutical ingredients using single reaction chamber digestion in compliance with USP requirements.
Muller AL; Oliveira JS; Mello PA; Muller EI; Flores EM
Talanta; 2015 May; 136():161-9. PubMed ID: 25702998
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of wavelength dispersive X-ray fluorescence spectrometry for the determination of metal impurities in pharmaceutical products and dietary supplements in view of regulatory guidelines.
Figueiredo A; Fernandes T; Costa IM; Gonçalves L; Brito J
J Pharm Biomed Anal; 2016 Apr; 122():52-8. PubMed ID: 26845202
[TBL] [Abstract][Full Text] [Related]
5. A direct LA-ICP-MS screening of elemental impurities in pharmaceutical products in compliance with USP and ICH-Q3D.
Pluháček T; Ručka M; Maier V
Anal Chim Acta; 2019 Oct; 1078():1-7. PubMed ID: 31358206
[TBL] [Abstract][Full Text] [Related]
6. Study of the use of axial viewed inductively coupled plasma atomic emission spectrometry with ultrasonic nebulization for the determination of select elemental impurities in oral drug products.
Menoutis J; Parisi A; Verma N
J Pharm Biomed Anal; 2018 Apr; 152():12-16. PubMed ID: 29414002
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an ICP-OES method for quantitation of elemental impurities in tablets according to coming US pharmacopeia chapters.
Støving C; Jensen H; Gammelgaard B; Stürup S
J Pharm Biomed Anal; 2013 Oct; 84():209-14. PubMed ID: 23850936
[TBL] [Abstract][Full Text] [Related]
8. Measurement uncertainty evaluation from correlated validation data: Determination of elemental impurities in pharmaceutical products by ICP-MS.
Milde D; Pluháček T; Kuba M; Součková J; Bettencourt da Silva RJN
Talanta; 2020 Dec; 220():121386. PubMed ID: 32928409
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Extractable Elements from Elastomers.
Paskiet D; Kraft C; Tullo E; Hunter J; Zurbriggen D
PDA J Pharm Sci Technol; 2019; 73(1):83-91. PubMed ID: 30030347
[TBL] [Abstract][Full Text] [Related]
10. Application of LA-ICP-MS as a rapid tool for analysis of elemental impurities in active pharmaceutical ingredients.
Rudovica V; Viksna A; Actins A
J Pharm Biomed Anal; 2014 Mar; 91():119-22. PubMed ID: 24440826
[TBL] [Abstract][Full Text] [Related]
11. Rapid screening of pharmaceutical products for elemental impurities by a high-resolution portable energy dispersive X-ray fluorescence spectrometer using an efficient fundamental parameter method.
Zhu L; Teng Y; Han W; Yin L; Teng X
Analyst; 2023 Feb; 148(5):1116-1122. PubMed ID: 36723086
[TBL] [Abstract][Full Text] [Related]
12. ICH Q3D based elemental impurities study in liquid pharmaceutical dosage form with high daily intake - comparative analysis by ICP-OES and ICP-MS.
Janchevska K; Stafilov T; Memed-Sejfulah S; Bogdanoska M; Ugarkovic S; Petrushevski G
Drug Dev Ind Pharm; 2020 Mar; 46(3):456-461. PubMed ID: 31999195
[TBL] [Abstract][Full Text] [Related]
13. Determination of ICH-Q3D Elemental Impurity Leachables in Glass Vials by Inductively Coupled Plasma Mass Spectrometry.
Breckenridge L; Oni Y; Evans C; Franck J; Wood S; Xu M; Sahin E; Zacour B
PDA J Pharm Sci Technol; 2023; 77(3):197-210. PubMed ID: 36241213
[TBL] [Abstract][Full Text] [Related]
14. A new ultrasound-assisted microextraction for elemental impurities determination in tablets by ICP-MS according to USP chapters 232 and 233.
Noronha IFPC; Pinheiro FC; Nascentes CC
Talanta; 2024 May; 271():125604. PubMed ID: 38219318
[TBL] [Abstract][Full Text] [Related]
15. Greening microwave-assisted digestion method using hydrogen peroxide for determination of elemental impurities by ICP-OES in antihypertensive active pharmaceutical ingredients.
Senger CM; Dornelles IS; Queiroz JM; Mello PA; Muller EI; Muller ALH
J Pharm Biomed Anal; 2024 Jan; 238():115802. PubMed ID: 37871418
[TBL] [Abstract][Full Text] [Related]
16. Method for determination of elemental impurities in metronidazole benzoate using inductively coupled plasma mass spectrometry.
Tian M; Zhang H; Fan H; Yin M; Wang W; Shi C
Eur J Mass Spectrom (Chichester); 2024 Feb; 30(1):60-64. PubMed ID: 37926973
[TBL] [Abstract][Full Text] [Related]
17. Elemental Impurities in Pharmaceutical Excipients.
Li G; Schoneker D; Ulman KL; Sturm JJ; Thackery LM; Kauffman JF
J Pharm Sci; 2015 Dec; 104(12):4197-4206. PubMed ID: 26398581
[TBL] [Abstract][Full Text] [Related]
18. Potential metal impurities in active pharmaceutical substances and finished medicinal products - A market surveillance study.
Wollein U; Bauer B; Habernegg R; Schramek N
Eur J Pharm Sci; 2015 Sep; 77():100-5. PubMed ID: 26036232
[TBL] [Abstract][Full Text] [Related]
19. Clean Chemistry for Elemental Impurities Analysis of Pharmaceuticals in Compliance with USP 232.
Jin C
AAPS PharmSciTech; 2016 Oct; 17(5):1141-9. PubMed ID: 26586536
[TBL] [Abstract][Full Text] [Related]
20. Elemental impurities in pharmaceutical products adding fuel to the fire.
Maithani M; Raturi R; Sharma P; Gupta V; Bansal P
Regul Toxicol Pharmacol; 2019 Nov; 108():104435. PubMed ID: 31376414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
